Filters

Drugs

Showing results (4691-4700 of 7,131) with videos related to

Pageof 714
Sort By:
Drugs|January 1, 1988
Comparative double-blind study of ketanserin versus propranolol in the treatment of essential hypertensionK Ito, T Omae, M Ikeda, et al.
Drugs|January 1, 1988
The therapeutic dilemma of hypertension in the elderlyS Julius
Drugs|January 1, 1988
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillinJ F Acar, L Gutmann, M D Kitzis
Drugs|January 1, 1988
Importance of beta-lactamases and clinical implications of their inhibitorsJ D Williams
Drugs|January 1, 1988
Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trialM F Güneren
Drugs|December 1, 1988
Neonatal sepsis. Progress in diagnosis and managementJ W St Geme, R A Polin
Drugs|February 12, 2019
Sintilimab: First Global ApprovalSheridan M Hoy
Drugs|February 2, 2019
L-Ornithine L-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver DiseaseAli Canbay, Jan-Peter Sowa
Drugs|February 2, 2019
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic EncephalopathyGerald Kircheis, Stefan Lüth
Drugs|January 1, 1988
The significance of gastrin in the pathogenesis and therapy of peptic ulcer diseaseC B Lamers
Pageof 714

Showing results (4691-4700 of 7,131) with videos related to

Sort By:
Pageof 714
Drugs|January 1, 1988
Comparative double-blind study of ketanserin versus propranolol in the treatment of essential hypertensionK Ito, T Omae, M Ikeda, et al.
Drugs|January 1, 1988
The therapeutic dilemma of hypertension in the elderlyS Julius
Drugs|January 1, 1988
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillinJ F Acar, L Gutmann, M D Kitzis
Drugs|January 1, 1988
Importance of beta-lactamases and clinical implications of their inhibitorsJ D Williams
Drugs|January 1, 1988
Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trialM F Güneren
Drugs|December 1, 1988
Neonatal sepsis. Progress in diagnosis and managementJ W St Geme, R A Polin
Drugs|February 12, 2019
Sintilimab: First Global ApprovalSheridan M Hoy
Drugs|February 2, 2019
L-Ornithine L-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver DiseaseAli Canbay, Jan-Peter Sowa
Drugs|February 2, 2019
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic EncephalopathyGerald Kircheis, Stefan Lüth
Drugs|January 1, 1988
The significance of gastrin in the pathogenesis and therapy of peptic ulcer diseaseC B Lamers
Pageof 714
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us